Company / Shares Outstanding
Rein Therapeutics, Inc. Shares Outstanding History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
21.7M
FY2025
5-year range
4.5M / 43.8M
FY2021-FY2025
Trend
+343.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding changed +343% YoY in FY2025, a notable deviation from the 8-year average annual change of +464%.
Based on SEC 10-K filings.
21666012.00 in FY2025 with a 5-year CAGR of -4.9%.
Increased from 4541167.00 to 21666012.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +68.5%
- 5-Year CAGR
- -4.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- Rein Therapeutics, Inc.'s shares outstanding has grown for 3 consecutive years.
- In FY2025, shares outstanding increased 343.5% year-over-year.
- Peak shares outstanding was recorded in FY2021.
- Lowest shares outstanding in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 21.7M | +343.5% |
| FY2024 | 4.9M | +7.6% |
| FY2023 | 4.5M | +0.3% |
| FY2022 | 4.5M | -89.7% |
| FY2021 | 43.8M | +57.5% |
| FY2020 | 27.8M | +88.6% |
| FY2019 | 14.7M | +0.2% |
| FY2018 | 14.7M | +3305.0% |
| FY2017 | 432.4K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026